24.91 USD
-0.03 (-0.12%)
We assign a fundamental rating of 3 out of 10 to CHSCN. CHSCN was compared to 87 industry peers in the Food Products industry. CHSCN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCN has a expensive valuation and it also scores bad on growth. CHSCN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHSCN had a positive cash flow from operations.
CHSCN had positive earnings in each of the past 5 years.
In the past 5 years CHSCN always reported a positive cash flow from operatings.
1.2 Ratios
CHSCN has a Return On Assets of 3.17%. This is in the better half of the industry: CHSCN outperforms 62.07% of its industry peers.
With a Return On Equity value of 5.40%, CHSCN perfoms like the industry average, outperforming 57.47% of the companies in the same industry.
CHSCN has a Return On Invested Capital of 0.49%. This is comparable to the rest of the industry: CHSCN outperforms 42.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHSCN is significantly below the industry average of 28.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROIC | 0.49% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
CHSCN has a Profit Margin (1.69%) which is comparable to the rest of the industry.
CHSCN's Profit Margin has improved in the last couple of years.
CHSCN's Operating Margin of 0.26% is in line compared to the rest of the industry. CHSCN outperforms 41.38% of its industry peers.
In the last couple of years the Operating Margin of CHSCN has declined.
CHSCN has a Gross Margin of 3.21%. This is amonst the worse of the industry: CHSCN underperforms 83.91% of its industry peers.
CHSCN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCN is destroying value.
Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.32 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCN has a Altman-Z score (2.32) which is in line with its industry peers.
A Debt/Equity ratio of 0.26 indicates that CHSCN is not too dependend on debt financing.
CHSCN's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. CHSCN outperforms 67.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.32 |
ROIC/WACC0.09
WACC5.43%
2.3 Liquidity
A Current Ratio of 1.53 indicates that CHSCN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.53, CHSCN perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
CHSCN has a Quick Ratio of 1.53. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHSCN (0.91) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
Looking at the last year, CHSCN shows a decrease in Revenue. The Revenue has decreased by -9.68% in the last year.
CHSCN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.54% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
96.55% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.44 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.63%, CHSCN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.42, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 90.80% of the companies listed in the same industry.
CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.63% |
5.2 History
CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
28.20% of the earnings are spent on dividend by CHSCN. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCN (12/31/2025, 8:00:01 PM)
24.91
-0.03 (-0.12%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.45%
Inst Owner Change1043.08%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap305.65M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.63% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years10
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.48 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.44 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY208.01%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROCE | 0.67% | ||
| ROIC | 0.49% | ||
| ROICexc | 0.5% | ||
| ROICexgc | 0.5% | ||
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.9 | ||
| Cap/Depr | 111.84% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 85.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.43%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 7.1 PERP / CHSCN FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
What is the valuation status for CHSCN stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
What is the profitability of CHSCN stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.
Can you provide the financial health for CHSCN stock?
The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.